135 related articles for article (PubMed ID: 16079484)
1. Pilocarpine-induced seizure susceptibility in rats following prenatal methylazoxymethanol treatment.
Choi IS; Cho JH; Lee MG; Choi BJ
Biol Pharm Bull; 2005 Aug; 28(8):1408-13. PubMed ID: 16079484
[TBL] [Abstract][Full Text] [Related]
2. Altered glutamate receptor - transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero.
Harrington EP; Möddel G; Najm IM; Baraban SC
Epilepsia; 2007 Jan; 48(1):158-68. PubMed ID: 17241223
[TBL] [Abstract][Full Text] [Related]
3. Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model.
Colciaghi F; Nobili P; Cipelletti B; Cagnoli C; Zambon S; Locatelli D; de Curtis M; Battaglia GS
Neuropharmacology; 2019 Jul; 153():82-97. PubMed ID: 31047919
[TBL] [Abstract][Full Text] [Related]
4. Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies.
Germano IM; Sperber EF
J Neurosci Res; 1998 Feb; 51(4):473-88. PubMed ID: 9514201
[TBL] [Abstract][Full Text] [Related]
5. Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol.
Chevassus-au-Louis N; Ben-Ari Y; Vergnes M
Brain Res; 1998 Nov; 812(1-2):252-5. PubMed ID: 9813354
[TBL] [Abstract][Full Text] [Related]
6. Excitability of CA1 neurons in the model of malformation-associated epilepsy.
Choi IS; Cho JH; Kim JH; Jung SC; Bae YC; Lee MG; Choi BJ
Neuroreport; 2004 Jul; 15(10):1639-42. PubMed ID: 15232298
[TBL] [Abstract][Full Text] [Related]
7. Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol.
Bassanini S; Hallene K; Battaglia G; Finardi A; Santaguida S; Cipolla M; Janigro D
Neurobiol Dis; 2007 May; 26(2):481-95. PubMed ID: 17398107
[TBL] [Abstract][Full Text] [Related]
8. Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia.
Colciaghi F; Finardi A; Frasca A; Balosso S; Nobili P; Carriero G; Locatelli D; Vezzani A; Battaglia G
Brain; 2011 Oct; 134(Pt 10):2828-43. PubMed ID: 21482549
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels.
Fiore M; Korf J; Antonelli A; Talamini L; Aloe L
Neurotoxicol Teratol; 2002; 24(2):179-91. PubMed ID: 11943506
[TBL] [Abstract][Full Text] [Related]
10. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment.
Baraban SC; Schwartzkroin PA
Epilepsy Res; 1996 Apr; 23(3):189-94. PubMed ID: 8739122
[TBL] [Abstract][Full Text] [Related]
11. Postnatal behavior in hatano high- and low-avoidance rats following prenatal exposure to low-dose methylazoxymethanol.
Ohta R; Matsumoto A; Sato M; Shirota M; Nagao T; Tohei A; Taya K
Neurotoxicol Teratol; 2000; 22(3):405-13. PubMed ID: 10840184
[TBL] [Abstract][Full Text] [Related]
12. NPY sensitivity and postsynaptic properties of heterotopic neurons in the MAM model of malformation-associated epilepsy.
Pentney AR; Baraban SC; Colmers WF
J Neurophysiol; 2002 Nov; 88(5):2745-54. PubMed ID: 12424309
[TBL] [Abstract][Full Text] [Related]
13. Prenatal methylazoxymethanol exposure alters evoked responses in fetal rats.
Kleven GA; Queral L; Robinson SR
Neurotoxicol Teratol; 2004; 26(5):663-71. PubMed ID: 15315815
[TBL] [Abstract][Full Text] [Related]
14. Abnormal development of serotonin nerve fibers in the visual cortex in rats with methylazoxymethanol-induced microcephaly.
Funahashi A; Fujimiya M; Kimura H; Maeda T
Acta Neuropathol; 1998 Jan; 95(1):5-14. PubMed ID: 9452817
[TBL] [Abstract][Full Text] [Related]
15. CNS autoimmune response in the MAM/pilocarpine rat model of epileptogenic cortical malformation.
Costanza M; Ciotti A; Consonni A; Cipelletti B; Cattalini A; Cagnoli C; Baggi F; de Curtis M; Colciaghi F
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2319607121. PubMed ID: 38635635
[TBL] [Abstract][Full Text] [Related]
16. Behavioral perturbations after prenatal neurogenesis disturbance in female rat.
Hazane F; Krebs MO; Jay TM; Le Pen G
Neurotox Res; 2009 May; 15(4):311-20. PubMed ID: 19384565
[TBL] [Abstract][Full Text] [Related]
17. Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate.
de Feo MR; Mecarelli O; Ricci GF
Pharmacol Res; 1995 Feb; 31(2):109-14. PubMed ID: 7596953
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal hyperactivity induced by prenatal methylazoxymethanol administration as measured in a computerized residential maze.
Balduini W; Lombardelli G; Peruzzi G; Cattabeni F; Elsner J
Neurotoxicol Teratol; 1989; 11(4):339-43. PubMed ID: 2796888
[TBL] [Abstract][Full Text] [Related]
19. Abnormal connections in the malformed cortex of rats with prenatal treatment with methylazoxymethanol may support hyperexcitability.
Chevassus-Au-Louis N; Jorquera I; Ben-Ari Y; Represa A
Dev Neurosci; 1999 Nov; 21(3-5):385-92. PubMed ID: 10575262
[TBL] [Abstract][Full Text] [Related]
20. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
